Fresh French fund for healthcare

The fund has drawn interest from international investors, insurance companies and family offices, alongside the Biotech & Healthcare Acceleration Fund (FABS) operated by Bpifrance in the context of the Investments for the Future Program (PIA) managed by General Commissariat for Investment (CGI). Created in 2016 as an extension of the iBionext network established in 2012, iBionext Growth Fund is positioned as the missing link in the financing chain of innovative healthcare companies.

Alexia Perouse, CEO & Managing Partner of iBionext, commented: “We are delighted to have generated such momentum around our unique initiative and we thank our investors for the confidence they have placed in us. iBionext operates with a very entrepreneurial approach designed to meet the challenges that innovative healthcare companies can face, from creation to growth, with the goal of creating leaders in their field.”

The most notable creation of the iBionext network was GenSight Biologics, one of the few biotechs to successfully go public this year.